Sustainability and affordability of cancer drugs: A novel pricing model

60Citations
Citations of this article
89Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The affordability of newly approved anticancer agents is a challenge to many national health services and reimbursement systems. Therefore, we have developed an approach based upon the adoption of a novel model of price setting and herein provide examples of how it might be implemented. This model is intended to alter the balance between social and economic entrepreneurship.

Cite

CITATION STYLE

APA

Uyl-De Groot, C. A., & Löwenberg, B. (2018). Sustainability and affordability of cancer drugs: A novel pricing model. Nature Reviews Clinical Oncology, 15(7), 405–406. https://doi.org/10.1038/s41571-018-0027-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free